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Open access under CC BSubtle regional differences in microglial phenotype exist in the adult mouse brain. We investigated
whether these differences were ampliﬁed during ageing and following systemic challenge with lipopoly-
saccharide (LPS). We studied microglial morphology and phenotype in young (4mo) and aged (21mo)
C57/BL6 mice using immunohistochemistry and quantiﬁed the expression levels of surface molecules
on microglia in white and grey matter along the rostral-caudal neuraxis. We detected signiﬁcant regional,
age dependent differences in microglial phenotypes, with the microglia of white matter and caudal areas
of the CNS exhibiting greater upregulation of CD11b, CD68, CD11c, F4/80 and FccRI than grey matter and
rostral CNS areas. Upregulation of CD11c with age was restricted to the white matter, as was the appear-
ance of multinucleated giant cells. Systemic LPS caused a subtle upregulation of FccRI after 24 h, but the
other markers examined were not affected. Burrowing behaviour and static rod assays were used to
assess hippocampal and cerebellar integrity. Aged mice exhibited exaggerated and prolonged burrowing
deﬁcits following systemic LPS injection, while in the absence of an inﬂammatory challenge aged mice
performed signiﬁcantly worse than young mice in the static rod test. Taken together, these ﬁndings show
that the effects of age on microglial phenotype and functional integrity vary signiﬁcantly between CNS
compartments, as do, albeit to a lesser extent, the effects of systemic LPS.
 2011 Elsevier Inc. Open access under CC BY license.1. Introduction
Microglia are the resident immunocompetent and phagocytic
cells in the CNS that play a critical role in normal functioning of
the CNS. They respond to injury, damage and pathogens by rapidly
changing their phenotype and secretion of a plethora of soluble
factors. The microglia also play a key role in the communication
of systemic infection and inﬂammation to the brain resulting in
behavioural changes, but this signalling is not detrimental to the
adult healthy brain and rather contributes to recovery and mainte-
nance of homeostasis (Dantzer and Kelley, 2007; Teeling and Perry,
2009). Microglia can become activated or ‘primed’ in chronic neu-
rodegenerative or inﬂammatory diseases, and these primed cells,
in contrast to the normal resident microglia, have a lower thresh-
old for activation and can become harmful upon further stimula-
tion (Cunningham et al., 2009; Perry et al., 2010). The normal
ageing process can also induce microglia priming (Chen et al.,
2008; Frank et al., 2010; Godbout et al., 2005) but the mechanism
underlying these age-related changes in microglial cells are not
understood. This study aimed to investigate if the age-relatedgical Sciences, University of
na Road, Southampton SO16
Y license.changes in microglia phenotype show regional differences and
whether these are associated with functional changes or previously
described age-related changes in neuronal integrity.
Microglial cells are long lived, myeloid-derived cells that popu-
late the CNS during early development (Alliot et al., 1999; Ginhoux
et al., 2010; Lawson et al., 1992). It is estimated that the adult
mouse brain contains approximately 3.5 million microglia (Lawson
et al., 1990; Long et al., 1998). Their morphology and density, how-
ever, is region speciﬁc and can range from 5% up to 12% of total
cells per region, with higher densities found in the grey matter
(Lawson et al., 1990). The distribution and phenotype of microglia
also differs between regions in the human brain but, in contrast to
rodents, the white matter contains signiﬁcantly more microglia,
about 13% of total glial cell density, with grey matter showing a
low microglial density (Mittelbronn et al., 2001).
To gain more insight into the cellular functions of microglia in
the adult mouse brain, De Haas et al. (2008) compared the cellular
expression level of a number of functional surface molecules in dif-
ferent brain regions and found distinct regional differences. For
example, the expression levels of CD11b and CD40 in the cerebral
cortex were signiﬁcantly lower than the levels in the spinal cord.
The different regional expression of some immune molecules on
microglia may reﬂect different aspects of microglial activation,
which is of interest in the context of the rostro-caudal gradient
of reactivity to injury and inﬂammatory stimuli in the CNS. Lesions
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blood–brain barrier breakdown than comparable lesions to cortex
(Schnell et al., 1999a). The rostro-caudal gradient is also observed
following focal cytokine injections with more overt leucocyte
recruitment in the caudal than forebrain regions (Phillips and
Lampson, 1999; Phillips et al., 1999; Schnell et al., 1999b).
With age the distribution and number of microglia changes lit-
tle, if at all (Deng et al., 2006; Long et al., 1998; Ogura et al., 1994).
In contrast, age-related changes in phenotype and functional prop-
erties of microglial cells have been widely reported. In the healthy
adult brain, microglia display a down-regulated phenotype charac-
terized by low expression of functionally relevant molecules such
as CD45, CD68 and MHC class II (Aloisi, 2001; Perry et al., 2007)
and a low phagocytic activity, but the expression levels of these
molecules increase after acute CNS injury or ageing (Conde and
Streit, 2006; DiPatre and Gelman, 1997; Ogura et al., 1994; Perry
et al., 1993; Rogers et al., 1988; Streit, 1996). In the aged rat brain
there is an increase in CD68 + cells throughout the parenchyma in
both grey and white matter and appearance of MHCII positive
aggregates of cells in and adjacent to white matter (Perry et al.,
1993). Similar changes have been observed in aged mice. These
changes have been associated with an increased sensitivity to sys-
temic inﬂammatory challenge with increased cytokine production
and altered behavioural responses (Barrientos et al., 2006; Chen
et al., 2008; Henry et al., 2009; Wynne et al., 2010).
Many studies on age-related changes in microglia phenotype
and function during ageing have focused on single regions and
have not addressed possible regional differences within the CNS.
Microglia activation is evident in the white matter of the cerebral
hemispheres of old rats (Ogura et al., 1994), old monkeys (Shefﬁeld
and Berman, 1998; Sloane et al., 1999), and elderly humans (Simp-
son et al., 2007), and it has been reported that the extent of microg-
lial cell activation in white matter, as measured by increased
expression of MHCII and iNOS, is related to the degree of cognitive
impairment (Sloane et al., 1999). The aim of this study was to com-
pare the phenotype and morphology of microglia in various re-
gions of young (4 months) and aged (21 months) mouse brain
using a range of functional surface markers and to assess their phe-
notype following a systemic inﬂammatory challenge. We selected
eight distinct regions of grey or white matter distributed along a
rostral-caudal neuraxis. The regions included in our study were:
striatum, corpus callosum, ﬁmbria, dentate gyrus, substantia nigra,
cerebellar nuclei, molecular layer of the cerebellar cortex and the
inferior cerebellar peduncle. The striatum is a mixed white/grey
matter region – we studied the most caudal segment of the puta-
men, an area that is mostly grey matter. The corpus callosum
and ﬁmbria are rostral white matter areas, while the dentate gyrus
is a grey matter region from the hippocampus. The substantia nigra
is a grey matter area caudal to the hippocampus with a particularly
high microglial density (Lawson et al., 1990). Within the cerebel-
lum we analysed the white matter tracts of the inferior cerebellar
peduncle, the deep cerebellar nuclei, which represent a mixture of
white and grey matter, and the molecular layer, which is grey mat-
ter neuropil of the cerebellar cortex.
The functional markers used in this study were selected for
their sensitivity to changes in the activation state of microglia
and their relevance to microglial function. CD11b and CD11c are
adhesion molecules that play a role in cell migration and phagocy-
tosis, CD68 is involved in phagocytosis and MHCII is important for
antigen presentation (Kettenmann et al., 2011). FccRs bind IgG,
and play a role in antigen presentation and uptake of opsonised cell
debris (Nimmerjahn and Ravetch, 2008). F4/80 contributes to
peripheral tolerance induction in T regulatory cells by myeloid
cells (Lin et al., 2005), Dectin-1 is a non-TLR pattern recognition
receptor expressed during alternative activation of macrophages
(Shah et al., 2008) and DEC-205 is a dendritic cell marker involvedin antigen presentation (Jiang et al., 1995). These markers are mye-
loid cellspeciﬁc within the CNS and up-regulated upon cell activa-
tion (Buttini et al., 1996; Lunnon et al., 2011; Ponomarev et al.,
2005; Qin et al., 2004; Shah et al., 2008). In this study we show that
microglial age-related phenotypes vary regionally, with evidence
of a differential expression of myeloid antigens along the rostro-
caudal neuraxis. These phenotype differences correlate with age-
related behavioural deﬁcits dependent on hippocampus and cere-
bellum integrity.2. Materials and methods
2.1. Animals and procedures
Female C57BL/6 mice (Harlan, UK, bred in house) were used in
all experiments. Mice were housed in groups of 5–10 in plastic
cages with sawdust bedding and standard chow diet and water
available ad libitum. The holding room temperature was kept be-
tween 19 and 23 C with a 12:12 h light–dark cycle (light on at
0700 h). Young mice were 4 months old and aged mice were 20–
21 months old (n = 10–15 per treatment group). Changes in behav-
iour and microglial phenotype were assessed in the same cohort of
mice. All procedures were performed under the authority of a UK
Home Ofﬁce License in accordance with the UK animals (Scientiﬁc
Procedures) Act 1986, and after obtaining local ethical approval by
the University of Southampton.2.2. LPS administration
Mice were injected intraperitoneally with saline or LPS at a dose
of 100 lg/kg (L5886, Salmonella abortus equi, Sigma, Poole, UK).2.3. Burrowing
Burrowing behaviour was assessed as described previously
(Teeling et al., 2007). Brieﬂy, plastic cylinders 20 cm long and
6.8 cm in diameter and ﬁxed at a slight incline were ﬁlled with
190 g of normal food diet pellets and placed in individual cages.
Burrowing activity was measured between 3 and 5 h after saline
or LPS injection by weighing the amount of displaced food pellets,
after which the tube was reﬁlled to measure overnight burrowing
activity. Baseline burrowing activity over 2 h or overnight was
determined for each mouse 24 h prior to the experiment to allow
the expression of data as percentage of baseline activity.2.4. Multiple static rod test
Static rod test performance was assessed as previously de-
scribed (Contet et al., 2001) with minor adaptations. Three wooden
rods of varying diameter (35, 22 and 9 mm) each 60 cm long were
ﬁxed on one end to a supporting platform and suspended 60 cm
above a bed of foam. A mouse was placed at the end of the rod fac-
ing towards the open end. The time taken to orientate 180 degrees
(‘‘orientation’’) and the time to travel to the wooden platform
(‘‘transit time’’) were then noted. If the mouse failed to reach the
wooden platform, it was assigned a score of ‘‘fail’’. The multiple
static rod test was performed between 1 and 2 h after saline or
LPS injection. A baseline measurement was taken 24 h prior to
the experiment. Prior to baseline mice were habituated to all three
rods. All mice successfully traversed the two larger rods, therefore
only data from the smallest rod is presented.
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An L-shaped metal rod of 2 mm diameter and 28 cm length was
suspended from a wire mesh screen 0.5 m above a bed of foam. The
mouse was placed at the bottom of the rod and allowed to climb
for 60 s to reach the wire mesh screen. Mice were scored as fol-
lows: fell within 10 s (=1), 25 s (=2) or 59 s (=3), remained on
the rod for > 60 s (=4), or reached the inverted screen within 60 s
(=5), 25 s (=6), or 10 s (=7).
2.6. Tissue processing and immunohistochemistry
24 h after LPS or saline injection mice received a terminal dose
of pentobarbital and, following transcardiac perfusion with hepa-
rinised saline, brain and spleen tissue were immediately removed,
embedded and frozen in optimal cutting temperature (OCT) med-
ium (Sakura Finetek, Thatcham, UK). 10 lm sections were cut on
a cryostat in the coronal plane at 0.9, 3.0 or 6.0 mm ± 0.3 mm
from bregma, air dried and frozen at 20 C until required.
For immunohistochemical analysis, sections were dried at 37 C
and ﬁxed for 10 min in 100% ethanol at 4 C. Sections were then
quenched with 3% hydrogen peroxide (Sigma, Poole, UK) in phos-
phate buffered saline (PBS) and blocked with appropriate 10% ani-
mal serum (Vector Laboratories, Peterborough, UK) and 1% bovine
serum albumin (Fisher Scientiﬁc, Loughborough, UK). Primary anti-
bodies were incubated overnight at 4 C, for details see Table 1.
Biotinylated secondary antibodies, either rabbit-anti-rat IgG or
goat-anti-hamster IgG (Vector Laboratories, Peterborough, UK),
were added for 45 min, followed by exposure to avidin biotin
complexes (Vector Laboratories, Peterborough, UK) and DAB
(3,30-Diaminobenzidine) (Sigma, Poole, UK). Sections were coun-
terstained with Harris haematoxylin (Sigma, Poole, UK). If prepared
for immunoﬂuorescence sections were incubated with a donkey-
anti-rat or goat-anti-rabbit IgG secondary antibody conjugated
with a 488 or 568 nm ﬂuorophore (Invitrogen, Paisley, UK) or with
biotinylated secondary antibodies followed by 488 or 568 nm ﬂuo-
rophore conjugated streptavidin (Invitrogen, Paisley, UK). Speciﬁc-
ity of primary antibodies was conﬁrmed using spleen as a positive
control and omission of the primary antibody as a negative control.
The speciﬁcity of FccRI staining was conﬁrmed using brain tissue
from ME7 infected Fc gamma chain deﬁcient mice.
2.7. Quantiﬁcation of immunohistochemistry
Images were analysed and quantiﬁed using ImageJ. The DAB
and haematoxylin channels were isolated using a plugin and a
threshold was determined for quantiﬁcation. Thresholds were
determined for each experiment to control for variation in DAB
staining intensity between experiments. Background or exces-
sively dark haematoxylin staining was removed using the ‘‘despec-
kle’’ setting and, when required, by superimposing a mask of theTable 1
List of primary antibodies used.
Antibody target Clone Animal of origin
CD11b 5C6 Rat-anti-mouse
CD11c N148 Hamster-anti-mouse
CD68 FA-11 Rat-anti-mouse
F4/80 CI:A-1 Rat-anti-mouse
FccRI 290322 Rat-anti-mouse
MHCII M5/114.15.2 Rat-anti-mouse
CD16/32 FCR4G8 Rat-anti-mouse
Dectin-1 218820 Rat-anti-mouse
Ki67 Polyclonal Rabbit-anti-mouse
DEC-205 NLDC-145 Rat-anti-mouse
Collagen IV Polyclonal Rabbit-anti-mousehaematoxylin channel onto the image. The region of interest was
traced by ‘‘freehand’’ from the image and the average pixel density
within the selected area was calculated. For each animal (n = 4–5
per treatment group), two images per region of interest were cap-
tured at 20 magniﬁcation for quantiﬁcation, using a brain atlas to
identify matching regions of interest in each hemisphere. The aver-
age pixel density above threshold of the two images was calculated
and data expressed as fold increase over 4 month old, saline trea-
ted expression levels in the same region. FccRI expression in the
striatum was excluded from analysis due to non-speciﬁc nuclear
binding in this particular region.2.8. Quantitative PCR
Brain tissue was rapidly removed following perfusion and dis-
sected to separate the cerebellum from a coronal section of hippo-
campus, thalamus and cortex (bregma -1.5 mm to -3.5 mm). The
coronal section was divided into two hemispheres, snap frozen in
liquid nitrogen and stored at -80 C. Total RNA was extracted from
brain tissue using RNeasy mini kits (Qiagen, Crawley, UK) and trea-
ted with DNAse I to remove any contaminating gDNA (Qiagen).
cDNA was synthesised using reverse transcription reagents from
Applied Biosystems (Warrington, UK). SYBR green super mix (Bio-
Rad, Hemel Hempstead, UK) was used to detect ampliﬁcation of
primer products. IL-1b primers were purchased from Invitrogen
and iNOS, GAPDH and IL-6 primers were purchased from Sigma,
Poole, UK. Primer sequences are as previously described (Palin
et al., 2008; Sato et al., 2003). Samples were quantiﬁed against a
standard curve using mouse hippocampus tissue infected with
ME7, injected intraperitoneally with LPS and collected 6 h after
injection as a positive control. The amount of mRNA was then esti-
mated as the ratio of GAPDH. n = 3–4 per treatment group.2.9. Statistical analysis
Data sets were tested for a normal distribution using the
D’agostino-Pearson omnibus test. All tests were performed in
either Sigmaplot 11.0 or GraphPad Prism 5.0. Overnight burrowing
data was normally distributed and was analysed using two way
ANOVAs with Holm-Sidak post tests. Two hour burrowing data
was not normally distributed and was therefore analysed using
Mann–Whitney tests on saline and LPS groups. Pass/fail data from
the multiple static rod tests was analysed using a Chi squared test.
Transit time data was analysed using a Mann–Whitney test. Quan-
tiﬁcation of the immunohistochemical analysis was performed by
expressing data as fold increase from the mean of the 4 month
old saline values from the same brain region, logarithmically trans-
formed and analysed using a three way ANOVA with Holm-Sidak
post tests. Quantitative PCR data was logarithmically transformed
and analysed by two way ANOVA and Holm-Sidak post tests.Source
Serotec (Oxford, UK)
Kind gift from Prof. M. Glennie (University of Southampton)
Serotec (Oxford, UK)
Serotec (Oxford, UK)
R&D Systems (Abingdon, UK)
Abcam (Cambridge, UK)
Serotec (Oxford, UK)
R&D Systems (Abingdon, UK)
Abcam (Cambridge, UK)
Serotec (Oxford, UK)
Serotec (Oxford, UK)
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3.1. Microglial morphology changes with age
Many, but not all, microglia exhibited a change in morphology
in the aged brain (Figs. 1 and 2), including a thickening and de-
ramiﬁcation of processes and hypertrophy of the cell body
(Fig. 1C and G). Morphological changes were observed in all re-
gions studied, and microglia broadly retained the pattern that
has previously been reported in grey versus white matter (Lawson
et al., 1990), with longitudinal processes that run parallel to the ax-
onal tracts in the white matter and radially branched microglia in
the grey matter. Aged mice exhibited cell aggregates of approxi-
mately 20–30 lm in diameter, containing multiple nuclei and few-
er, shorter, highly thickened processes (Fig. 1G, H, P). Some
aggregates contained as many as 6 or 7 nuclei. These aggregates
were predominantly found in the white matter, particularly in
the cerebellum (Fig. 1G, H, P). Our results further show that sys-
temic LPS challenge did not appear to change the morphology ofFig. 1. CD11b and CD68 marker expression increases with age and LPS. (A–H) CD11b. (A
saline, D – 21 month old LPS. (E–G) Cerebellum. E – 4 month old saline, F – 4 month old LP
4 month old saline, J – 4 month old LPS, K – 21 month old saline, L – 21 month old LPS.
saline, P – 21 month old LPS.the microglia or the number of multinucleate aggregates observed
in aged mice (Fig. 1).3.2. Microglial phenotype changes with age
In addition to morphological changes we noted distinct pheno-
typic changes in the aged brain, including increased expression of
CD11b (Fig. 1A–H), CD68 (Fig. 1I–P), CD11c (Fig. 2D and G), FccRI
(Fig. 2E and H) and F4/80 (Fig. 2F and I). The phenotype changes
were more pronounced in the cerebellum compared to the hippo-
campus. Increased levels of CD68 were found on microglia in the
white matter regions of the cerebellum of aged brain, while in
the young brain immunoreactivity for this marker was predomi-
nantly associated with perivascular macrophages (Fig. 1M and
O). Double immunoﬂuorescence showed that cell aggregates in
the aged brain are microglia as CD11b positive aggregates were
not associated with blood vessels and mainly found in the paren-
chyma, and are therefore not components of the perivascular mac-
rophage population (Fig. 2A and B). Some aggregates extended–D) Hippocampus. A – 4 month old saline, B – 4 month old LPS, C – 21 month old
S, G – 21 month old saline, H – 21 month old LPS. (I–P) CD68. (I–L) Hippocampus. I –
(M–P) Cerebellum. M – 4 month old saline, N – 4 month old LPS, O – 21 month old
Fig. 2. Microglial membrane marker expression increases with age. (A, B) Double immunoﬂuorescence staining for CD11b (green) and collagen IV (red) in the ﬁmbria (A) and
cerebellar inferior peduncle (B) of a 21 month old mouse. CD11b positive cell aggregates are indicated by white arrows. The aggregates contain multiple nuclei and are not
situated directly adjacent to blood vessels, as indicated by collagen IV positive basement membranes. Nuclei are blue after DAPI staining. (C) Double immunoﬂuorescence
staining for CD11c (green) and Ki67 (red), a marker of proliferation, in the cerebellar inferior peduncle. CD11c positive aggregates do not co-localise with Ki67 positive nuclei.
D&G – CD11c staining in the cerebellar inferior peduncle of a 21 month old (D) and 4 month old (G) mouse. E&H – FccRI staining in the cerebellar inferior peduncle of a
21 month old (E) and 4 month old (H) mouse. F&I – F4/80 staining in the cerebellar inferior peduncle of a 21 month old (F) and 4 month old (I) mouse.
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We also show that these aggregates were not groups of proliferat-
ing cells by double staining for CD11c and Ki67 (Fig. 2C). Expres-
sion of CD11c, FccRI and F4/80 was very weak or not detectable
in the 4 month old brain (Fig. 2G–I), but all three markers were ro-
bustly expressed in aged cerebellar white matter (Fig. 2D–F). In
summary, age dependent changes in morphology and phenotype
appear to arise in a region dependent manner, with a speciﬁc white
matter phenotype present in the aged brain, in particular in the
cerebellum.
3.3. Quantiﬁcation of microglial phenotype changes with age: CD11b,
CD68 and F4/80
We quantiﬁed the expression levels of functional markers in the
different regions studied. In the ageing brain an increased expres-
sion of CD11b, CD68 and F4/80 (Fig. 3, n = 5 per group): for all three
markers there was a strong effect of age on expression level
(CD11b: F(1,111) = 38.35, p < 0.001; CD68: F(1,108) = 271.36, p <
0.001; F4/80: F(1,109) = 75.86, p < 0.001). None of these markers
were signiﬁcantly affected by systemic LPS 24 h after injection. Re-
gion had a strong effect on expression of all three markers, (CD11b:
F(7,111) = 2.45, p = 0.022; CD68: F(7,108) = 7.90, p < 0.001; F4/80:F(7,109) = 4.64, p < 0.001). We detected an interaction between age
and region for expression of all three markers (CD11b: F(7,111) =
2.12, p = 0.047; CD68: F(7,108) = 7.789, p < 0.001; F4/80:
F(7,109) = 4.64, p < 0.001), suggesting that microglial activation is
differentially affected by age in different brain regions. The in-
creases in expression of CD11b, CD68 and F4/80 were greatest in
the cerebellum and in particular in the cerebellar inferior pedun-
cles. Microglial expression of all three markers in the ﬁmbria and
for CD11b and CD68 the corpus callosum was also strongly in-
creased in aged animals (Fig. 3A and B). Changes in the expression
of these molecules in the white matter were greater than those in
the grey matter. The dentate gyrus did not exhibit any changes in
expression with ageing for any of these three markers.
3.4. Quantiﬁcation of microglial phenotype changes with age: CD11c
and FccRI
The expression levels of CD11c (Fig. 4A) and FccRI (Fig. 4B) were
also quantiﬁed and expression of both was signiﬁcantly increased
by age (CD11c: F(1,128) = 63.08, p < 0.001; FccRI: F(1,92) = 61.37,
p < 0.001), region (CD11c: F(7,128) = 15.76, p < 0.001; FccRI:
F(6,92) = 4.84, p < 0.001) and, for FccRI, LPS injection (F(1,92) = 5.97,
p < 0.05). An interaction between age and region was detected for
Fig. 3. Age related changes in microglial phenotype depends on brain region. Tissue collected and analysed 24 h after intraperitoneal injection of saline or LPS. (A) CD11b
expression in selected regions of the CNS. CD11b expression was signiﬁcantly inﬂuenced by age, region and age  region (p < 0.05), but not LPS. n = 4–5 per region. (B) CD68
expression in selected regions of the CNS. CD68 expression was signiﬁcantly inﬂuenced by age, region and age  region, but not LPS (p < 0.001). n = 4–5 per region. (C) F4/80
expression in selected regions of the CNS. F4/80 expression was signiﬁcantly inﬂuenced by age, region and age  region (p < 0.001), but not LPS. n = 4–5 per region. Horizontal
bars denote a signiﬁcant effect of age (4 m saline to 21 m saline) or LPS (21 m saline to 21 m LPS) within that region. Data is shown as mean ± SEM. ⁄ denotes p < 0.05; ⁄⁄
denotes p < 0.01; ⁄⁄⁄ denotes p < 0.001.
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ingly, CD11c expression was up-regulated exclusively in whitematter regions during ageing. All four white matter regions exam-
ined demonstrated a signiﬁcant increase in CD11c expression with
Fig. 4. Age related changes in CD11c and FccRI expression depends on brain region. Tissue collected and analysed 24 h after intraperitoneal injection of saline or LPS. (A)
CD11c expression in selected regions of the CNS. CD11c expression was signiﬁcantly inﬂuenced by age, region and age  region (p < 0.001), but not LPS. n = 5 per region. (B)
FccRI expression in selected regions of the CNS. FccRI expression was signiﬁcantly inﬂuenced by region, age and LPS (p < 0.05). n = 4–5 mice per region. Horizontal bars
denote a signiﬁcant effect of age (4 m saline to 21 m saline) or LPS (21 m saline to 21 m LPS) within that region. Data is shown as mean ± SEM. ⁄ denotes p < 0.05; ⁄⁄ denotes
p < 0.01; ⁄⁄⁄ denotes p < 0.001.
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inferior cerebellar peduncle, exhibited the greatest increase in
expression, but CD11c expression was not further inﬂuenced by
systemic LPS. Although expression of FccRI was increased in all re-
gions of the ageing brain, changes in FccRI expression were more
pronounced in white matter areas and the cerebellum than in
the hippocampus of 21 month old mice (Fig. 4B). FccRI expression
after LPS injection was also highest in the three cerebellar regions
investigated.
Changes in other molecules expressed by microglia during age-
ing and after systemic LPS injection were investigated in a qualita-
tive manner using immunohistochemistry (data not shown). A
small number of Dectin-1 positive cells were detected in the white
matter tracts of aged animals (3–4 cells per 20 ﬁeld of cerebel-
lum), but not in aged grey matter or young white matter. The
expression levels of Dectin-1 were not inﬂuenced by systemic
LPS. DEC-205 positive cells were not observed in either the young
or aged brain. We also investigated FccRII/III and MHCII expression
levels and the majority of positive cells were associated with blood
vessels. We could not detect any noticeable changes in the expres-
sion of these two molecules on microglia dependent on age or LPS.
In summary, age related changes in expression of microglia associ-
ated molecules varied greatly between different brain regions, with
the cerebellum and the white matter showing the most pro-nounced changes, while the effect of systemic LPS on microglia
associated molecule expression was limited to FccRI.
3.5. Aged animals show an exaggerated decline in burrowing in
response to systemic LPS
To investigate whether the age related, region speciﬁc changes
in microglial phenotype were associated with compromised CNS
function, we performed behavioural assays dependent on two of
the regions analysed for phenotype changes – the hippocampus
and the cerebellum. We used burrowing as a measure of hippo-
campus dependent sickness behaviours (Deacon et al., 2002). A
small decline in burrowing activity was seen at baseline with
age, which may be attributable to changes in baseline locomotor
activity (Supplementary Fig. 1). Between 3 and 5 h after a systemic
LPS injection all mice showed a decline in burrowing, with a great-
er decline in activity in aged mice compared to young mice
(Fig. 5A) (LPS group: p < 0.001, n = 14–15). Most 21 month old mice
failed to show any burrowing activity (median = 0%), whereas the
majority of 4 month old mice retained a degree of burrowing activ-
ity (median = 12.1%). There was no age-related effect of saline
injection on burrowing (p = 0.233, n = 10–15). At 24 h after injec-
tion the LPS-challenged mice had partially recovered their burrow-
ing activity (Fig. 5B), but this recovery was signiﬁcantly less in the
Fig. 5. Behavioural changes in young and aged mice and the effect of systemic inﬂammation. (A) Burrowing measured between 3 and 5 h after intraperitoneal injection of LPS
(100 lg/kg) or saline. Data shows systemic LPS induced a greater decline in 21 month old mice compared to 4 month old mice. Horizontal bars represent medians. (B)
Overnight burrowing after intraperitoneal injection of LPS or saline. Data shows that recovery of burrowing is slower in 21 month old mice compared to 4 month old mice.
Horizontal bars represent means. (C) Percentage fail rate in the 9 mm static rod test measured at baseline or between 1 and 2 h after intraperitoneal LPS or saline injection.
21 month old mice failed more frequently in the 9 mm static rod test than 4 months old. This change in performance was independent of strength (Supplementary Fig. 2).
Pass/fail ratios were not inﬂuenced by injection of saline (open bars) or LPS (black, ﬁlled bars). Columns represent the percentage of mice which fail the task. As this graph is
representation of binomial data drawn from a single experiment, no error bars are presented. (D) 9 mm static rod transit time to reach platform at baseline. Transit times
reﬂect a decline in performance with age. Data is shown as mean ± SEM. ⁄⁄⁄p < 0.001. Letters denote a signiﬁcant difference between groups (p < 0.05).
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21 month group p < 0.001. n = 14–15). Age and LPS both had a sig-
niﬁcant effect on overnight burrowing (Age: F1, 50 = 13.34,
p < 0.001. LPS: F1, 50 = 28.21, p < 0.0001). In addition, an interaction
between the two factors was detectable (F1, 50 = 5.053, p = 0.029).
To conclude, a systemic challenge of LPS led to an exacerbated
and decrease in burrowing activity in 21 month old mice when
compared to 4 month old mice.3.6. Static rod performance declines with age, but is not modulated by
systemic LPS
Next, we investigated a cerebellum dependent behaviour, the
multiple static rod test, which assesses the co-ordination and bal-
ance of mice on different diameter static rods (Carter et al., 1999;
Contet et al., 2001). Mice were placed on a suspended 9 mm diam-
eter static rod and the transit time to reach a platform after orien-
tation was assessed in saline and LPS-treated mice (Fig. 5C and D).
Chi squared analysis of baseline static rod performance showed a
signiﬁcant difference between young (7%, n = 30) and aged (68%,
n = 25) mice in pass/fail ratios on the 9 mm static rod ([2 = 22.69,
d.f. = 1, p < 0.0001) (Fig. 5C). Analysis of baseline transit times also
showed a signiﬁcant difference between young and aged mice
(Mann Whitney test, p < 0.0001, n = 25–30 per group) (Fig. 5D).
Injection of LPS or saline did not have a signiﬁcant effect on
pass/fail rates at any age and there were not sufﬁcient successful
completions of the test in the 21 month old mice to test for differ-
ences in transit times after injection. We also tested muscle
strength using the climbing rod test to investigate whetherchanges in muscle strength correlated with poorer static rod per-
formance. There was a decline in climbing rod performance with
age (p < 0.0001, Mann Whitney test; supplementary data Fig. 2A),
but we found no difference in climbing rod performance between
21 month old mice that passed or failed the static rod test (supple-
mentary data Fig. 2B). There was also no correlation between
climbing rod test performance and static rod transit time in
4 month old mice (Supplementary data Fig. 2C).
Finally we investigated the effect of LPS injection on the expres-
sion of inﬂammatory mediators in the different CNS regions of
aged and young mice using quantitative real time PCR. However,
we could not detect any signiﬁcant increase of IL-6, IL-1b or iNOS
mRNA expression 24 h after LPS injection in young or aged cerebel-
lum or hippocampus (data not shown).4. Discussion
In this study we have investigated the phenotype and morpho-
logical changes of microglia in eight distinct regions of the young
and aged mouse brain. We show that age-related phenotype
changes of microglial cells are more pronounced in the white mat-
ter, with the cerebellum, the most caudal structure studied, show-
ing the greatest differences.
Variations in microglial density have been well described in
adult mouse brain with the hippocampus and substantia nigra
exhibiting the highest and the cerebellar cortex the lowest density
of microglia (Lawson et al., 1990). A number of studies in several
areas of the CNS indicate that there is little, if any, change in the
distribution or numbers of microglia with age (Deng et al., 2006;
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known about phenotype changes in different regions of the aged
mouse brain. Our results are in accord with a recent study describ-
ing regional variation in expression levels of immunoregulatory
molecules in the healthy adult mouse brain. De Haas et al. showed
that regional differences between microglial phenotypes in the
adult mouse brain are subtle: expression levels of surface markers
such as CD11b, CD40 and the fractalkine receptor CX3CR1 ap-
peared higher in the microglia of the spinal cord and cerebellum
than the hippocampus (De Haas et al., 2008). In our study all func-
tional markers tested displayed the greatest increase in expression
with age in white matter regions, particularly in the cerebellum,
identifying a clear trend in phenotype changes along the rostro-
caudal axis in the aged mouse brain.4.1. Microglial phenotype changes in response to injury along the
rostro-caudal axis
Phenotype changes in microglia are well described in response
to acute and chronic injury or disease, but only a few studies have
looked at differential responsiveness to the grey matter versus the
white matter along the rostro-caudal neuraxis. Trauma-induced
lesions lead to a greater microglial response in the spinal cord than
the cortex or corpus callosum and the spinal white matter exhib-
ited a greater microgliosis than spinal grey matter (Batchelor et al.,
2008; Schnell et al., 1999a). Regional differences in responsiveness
to inﬂammatory stimuli are partly responsible for these observa-
tions, as stereotaxic injections of recombinant cytokines into the
striatum fail to evoke a robust response, while similar injections
into the spinal cord or brainstem are associated with BBB break-
down, microgliosis and secondary tissue damage (Campbell
et al., 2002; Phillips and Lampson, 1999; Phillips et al., 1999; Sch-
nell et al., 1999b). This regional difference in responsiveness to
inﬂammatory stimuli is also evident in EAE, which targets the
spinal cord rather than more rostral regions of the brain, such as
the forebrain (Sun et al., 2004). Collectively, these studies suggest
that the caudal and white matter regions of the CNS are more
responsive and therefore more vulnerable to inﬂammatory stim-
uli. Our study suggests that the differential sensitivity of these
microglial populations also applies to the ageing process. We show
that in the aged brain there is a greater up-regulation of CD11b,
CD11c, CD68, F4/80 and FccRI in white matter than in grey matter
and more in caudal areas than rostral areas. These data are in
agreement with previous studies in the aged rat brain suggesting
a rostral caudal gradient of microglial activation (Kullberg et al.,
2001).4.2. Pronounced white matter related changes
It has been previously reported that the microglia of the white
matter express greater levels of microglia associated molecules
with age than those of the grey matter (Kullberg et al., 2001; Perry
et al., 1993), and that the microglia may appear in ‘‘clumps’’ of
immunoreactive membranes in white matter (Perry et al., 1993;
Stichel and Luebbert, 2007). Our study shows that these aggregates
are not directly associated with blood vessels and are not clusters
of proliferating cells. Macrophages and microglia are known to
form multinucleate giant cells through fusion under a variety of
inﬂammatory conditions (Fendrick et al., 2007; Gasser and Most,
1999; Suzumura et al., 1999). Whether these cells are aggregates
of individual microglia or a single syncytium is not clear from
our study, but the appearance of multinucleate giant cells during
ageing would represent a signiﬁcant alteration in microglial phe-
notype and function.4.3. Pronounced changes in CD11c expression
We observed a signiﬁcant increase in CD11c expression levels,
predominantly in the white matter of the cerebellum. CD11c is a
protein found at high levels on dendritic cells, but is also found
on macrophages and microglia under neuroinﬂammatory condi-
tions (Reichmann et al., 2002; Remington et al., 2007). Increases
in CD11c immunoreactivity with age have been reported previ-
ously with robust CD11c expression in the aged white matter
and occasional CD11c expression throughout the grey matter
(Kaunzner et al., 2010; Stichel and Luebbert, 2007). These studies
describe CD11c positive cells as dendritic cells, as they express
DEC-205, MIDC8, MHCII and the co-stimulatory molecules CD80
and CD86. Using immunohistochemistry we did not detect DEC-
205 or MHCII expression in the aged brain. This discrepancy may
be explained by the superior sensitivity of alternative methods of
detection, such as ﬂow cytometry, or by the strain of mice used
(Henry et al., 2009). The functional consequence and mechanism
underlying increased expression of CD11c in the aged brain is un-
known, but increased turnover of myelin with age may be a con-
tributing factor (Ando et al., 2003). It has been shown that
engagement of low density lipoprotein receptor 1 (LRP-1) on mac-
rophages results in increased expression of CD11c (Cho et al., 2007;
Gower et al., 2011). Ligands for LRP-1 include low density lipopro-
tein (Kuchenhoff et al., 1997) and the myelin component MBP-1
(Gaultier et al., 2009). Whether the CD11c + cells in our study are
microglia that have taken up myelin components/breakdown
products, or inﬁltrating dendritic cells or macrophages remains to
be determined.
4.4. Neurodegeneration in the ageing brain
It is well recognised that the microglia are exquisitely sensitive
to neurodegeneration. However, in rodents and primates the ex-
tent to which neurodegeneration occurs in the ageing CNS varies
considerably from region to region. The substantia nigra (Ma
et al., 1999; Mouton et al., 2010) and cerebellum (Sturrock, 1989;
Woodruff-Pak et al., 2010) exhibit signiﬁcantly greater age-related
neuronal loss than the hippocampus (Calhoun et al., 1998; Rapp
and Gallagher, 1996) or striatum (Pesce and Reale, 1987), and sub-
stantial loss of myelinated axons has been reported in white mat-
ter regions (Bowley et al., 2010; Cavallotti et al., 2001; Sandell and
Peters, 2002, 2003). The areas with greatest neuronal loss are also
the regions that exhibit greater changes in microglial phenotype.
Whether neuronal loss drives microglial phenotype changes in
ageing, or if changes to the microglia precede and contribute to-
wards neuronal loss, is not known. There are however several
mechanisms by which neurons and oligodendrocytes keep microg-
lia in a quiescent state, such as interactions between CD200, frac-
talkine or CD47 and their cognate receptors on microglia (Gitik
et al., 2011; Hoek et al., 2000; Kong et al., 2007; Koning et al.,
2009; Lyons et al., 2009). Two studies in the healthy adult mouse
brain have revealed signiﬁcant regional variations in the distribu-
tion of these molecules. Koning et al. (2009) observed that
CD200 expression is greater in grey than white matter, which
may contribute to the regional differences in microglial phenotype
we report in this study. Fractalkine transcript expression has been
reported to be signiﬁcantly lower in the cerebellum and other cau-
dal areas such as the brainstem than the hippocampus or striatum,
which may help to explain the rostral caudal gradient of microglial
phenotype changes (Tarozzo et al., 2003). Decreased expression of
CD200 in the hippocampus and substantia nigra (Frank et al., 2006;
Wang et al., 2011), and of fractalkine in the hippocampus and fore-
brain have been demonstrated in aged mice (Lyons et al., 2009;
Wynne et al., 2010). Increased numbers of multinuclear giant cells
have also been observed in CD200-/- mice (Hoek et al., 2000), pro-
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of our study. A wider assessment of the expression of these immu-
noregulatory molecules in different regions of the aged brain and
how they may correlate with changes in microglial phenotype
would be of interest.4.5. Impact of systemic inﬂammation on aged-related microglia
phenotype
We anticipated an increase in expression levels of microglia
associated molecules after systemic LPS injection, which has previ-
ously been shown to up-regulate FccRI (Lunnon et al., 2011) and
CD11b (Buttini et al., 1996). However, the only molecule we found
to be sensitive to systemic LPS injection was FccRI. CD11b expres-
sion was not signiﬁcantly altered 24 h after systemic LPS challenge.
Furthermore, the effect of systemic LPS on FccRI expression was
subtle, region dependent and primarily observed in the white mat-
ter regions and the cerebellum of both young and aged mice. A la-
ter time point post injection, such as three days, may yield a more
robust effect on expression of these molecules (Buttini et al., 1996).4.6. Age-related functional deﬁcits
Since we had shown that the molecular expression patterns of
the microglia in distinct CNS regions were altered with age we
used behavioural assays to assess the functional integrity of two
regions, the hippocampus and the cerebellum. We demonstrate a
signiﬁcant age-related deﬁcit in static rod test performance and
veriﬁed that this was not dependent on loss of muscle strength.
There is a progressive loss of Purkinje neurons with age (Wood-
ruff-Pak et al., 2010) and Purkinje neuron speciﬁc degeneration
has previously been shown to compromise the performance of
mice in tasks assessing co-ordination and balance (Chen et al.,
1996; Kyuhou et al., 2006). A correlation of conditioned eye blink
response with Purkinje neuron numbers has also been previously
shown, suggesting that Purkinje cell loss may be the critical com-
ponent of age-related cerebellar dysfunction (Woodruff-Pak,
2006). LPS injection did not exacerbate deﬁcits in performance in
this task at any age, suggesting the cerebellar circuitry controlling
static rod performance is not sensitive to systemic LPS.
Burrowing is a hippocampus dependent (Deacon et al., 2002),
species typical behaviour that is sensitive to systemic inﬂamma-
tory challenge (Teeling et al., 2007). We demonstrated that aged
mice exhibit an exaggerated response and a delayed recovery
from systemic LPS challenge. Exaggerated sickness behaviour in
aged animals in response to systemic inﬂammatory challenge
has been previously reported (Barrientos et al., 2006; Godbout
et al., 2005, 2008; McLinden et al., 2011), but this is the ﬁrst study
to use burrowing in response to systemic LPS treatment in an
ageing context. Elevated levels of cytokines within the aged hip-
pocampus have been demonstrated following systemic inﬂamma-
tory challenge (Barrientos et al., 2009; Chen et al., 2008; Godbout
et al., 2005), which are likely produced by primed microglia in the
aging brain (Frank et al., 2010; Wynne et al., 2010). We were not
able to demonstrate the presence of inﬂammatory cytokines or
iNOS 24 h after systemic LPS injection in any brain region studied.
We had anticipated that elevation of these molecules would be
prolonged in aged animals in line with other studies (Godbout
et al., 2005; Wynne et al., 2010). This discrepancy may be due
to our use of a lower dose of LPS (100 lg/kg vs 330 lg/kg) and
a different sex and strain of mouse (male BALB/c vs female C57/
BL6). Our data does not however exclude the possibility of an
exaggerated local inﬂammatory at an earlier time-point following
systemic LPS injection.5. Summary
In this study we have demonstrated signiﬁcant differences in
microglial phenotypes between distinct regions of the aged brain.
The microglia of the white matter show more robust changes than
those of grey matter and there is evidence of a rostro-caudal gradi-
ent in the magnitude of these changes. The age-related changes in
microglia phenotype reported here may be of particular interest
when comparing studies in rodent and human material. In humans
white matter makes up 40% of the adult human brain (Gur et al.,
1999) compared to 10% in the mouse (Zhang and Sejnowski, 2000),
and human white matter contains a greater density of microglia
than grey matter (Mittelbronn et al., 2001), conversely to the
mouse (Lawson et al., 1990). The functional signiﬁcance of these
grey/white matter differences in microglial phenotype during age-
ing remain to be elucidated.
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